Thyroid hormone transporters in the human

Hormones

Volumn 10, Issue 4, 2011, Pages 270-279

  Karapanou, Olga ^a   Papadimitriou, Anastasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cerebral hypothyroidism; Mct8; Mct8 deficiency; Mental retardation; Oatp1c1

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; CARRIER PROTEIN; HORMONE RECEPTOR STIMULATING AGENT; LEVOTHYROXINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; OATP1B1 PROTEIN; OATP1C1 PROTEIN; ORGANIC ANION TRANSPORTER; THYROID HORMONE; THYROID HORMONE TRANSPORTER; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ALLAN HERNDON DUDLEY SYNDROME; BLOOD BRAIN BARRIER; CELL MEMBRANE TRANSPORT; CRITICAL ILLNESS; DEVELOPMENTAL DISORDER; DRUG MEGADOSE; GENE; GENE EXPRESSION; HEART FAILURE; HORMONE TRANSPORT; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; LIOTHYRONINE BLOOD LEVEL; LIVER; LOSS OF FUNCTION MUTATION; MONOCARBOXYLATE TRANSPORTER 8 DEFICIENCY; MONOCARBOXYLATE TRANSPORTER 8 GENE; MUSCLE HYPOTONIA; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; THYROTROPIN BLOOD LEVEL; X LINKED MENTAL RETARDATION;

EID: 84855482291     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1318     Document Type: Review

References (54)

1. Ord WM, 1898 The Bradshaw Lecture on Myxoedema and Allied Disorders: Delivered before the Royal College of Physicians. Br Med J 2: 1473-1479.
2. Bhatara V, Sankar R, Unutzer J, Peabody J, 2002 A review of the case for neonatal thyrotropin screening in developing countries: the example of India. Thyroid 12: 591-598.
3. Brent GA, 1994 The Molecular Basis of Thyroid Hormone Action. N Eng J Med 331: 847-853.
4. Yen PM, 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142.
5. Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM, Larsen PR, 1999 Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 140: 784-790.
6. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ, 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22: 451-476.
7. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ, 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278: 40128-40135.
8. van der Deure WM, Peeters RP, Visser TJ, 2007 Genetic variation in thyroid hormone transporters. Best Pract Res Clin Endocrinol Metab 21: 339-350.
9. Friesema EC, Jansen J, Milici C, Visser TJ, 2005 Thyroid hormone transporters. Vit Horm 70: 137-167.
10. Hagenbuch B, 2007 Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab 21: 209-221.
11. Svoboda M, Riha J, Wlcek K, Jaeger W, Thalhammer T, 2011 Organic anion transporting polypeptides (OAT Ps): regulation of expression and function. Curr Drug Metab 12: 139-153.
12. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al, 1995 Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109: 1274-1282.
13. Tamai I, Nezu J, Uchino H, et al 2000 Molecular identification and characterization of novel members of the human organic anion transporter (OAT P) family. Biochem Biophys Res Commun 273: 251-260.
14. van der Deure WM, Appelhof BC, Peeters RP, et al, 2008 Polymorphisms in the brain-specific thyroid hormone transporter OAT P1C1 are associated with fatigue and depression in hypothyroid patients. Clin Endocrinol 69: 804-811.
15. van der Deure M, Hansen PS, Peeters RP, et al, 2008 Thyroid hormone transport and metabolism by organic ion transporter 1C1 and consequences of genetic variation. Endocrinology 149: 5307-5314.
16. van der Deure WM, Peeters RP, Visser TJ, 2010 Molecu lar aspects of thyroid hormone transporters, including MCT8, MCT10, and OAT Ps, and the effects of genetic variation in these transporters. J Mol Endocrinol 44: 1-11.
17. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ, 2000 Organic ion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294: 73-79.
18. Merezhinskaya N, Fishbein WN, 2009 Monocarboxylate transporters: past, present, and future. Histol Histopathol 24: 243-264.
19. Halestrap AP, Meredith D, 2004 The SLC16 gene family from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447: 619-628.
20. Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP, 2005 Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem 280: 27213-27221.
21. Myrakami Y, Kohyama N, Kobayashi Y, et al, 2005 Functional characterization of human monocarboxylate transporter 6 (SLC16A5). Drug Metab Dispos 33: 1845-1851.
22. Bernal J, 2005 Pathophysiology of thyroid hormone deficiency during fetal development. J Pediatr Endocrinol Metab 18: Suppl 1: 1253-1256.
23. Heuer H, Maier MK, Iden S, et al, 2005 The monocarboxylate transporter 8 linked to psychomotor retardation is highly expressed in thyroid hormone-sensitive neuronal populations. Endocrinology 146: 1701-1706.
24. Leonard JL, Farwell AP, Yen PM, Chin WW, Stula M, 1994 Differential expression of thyroid hormone receptor isoforms in neurons and astroglial cells. Endocrinology 135: 548-555.
25. James SR, Franklyn JA, Reaves BJ, et al, 2009 Monocarboxylate transporter 8 in neuronal cell growth. Endocrinology 150: 1961-1969.
26. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH, 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol Endocrinol 20: 2761-2772.
27. Di Cosmo C, Liao X-H, Dumitrescu AM, Philp NJ, Weiss RE, Refetoff S, 2010 Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. J Clin Invest 120: 3377-3388.
28. Nishimura M, Naito S, 2008 Tissue-specific mRNA expression profiles of human solute carrier transporters superfamilies. Drug Metab Pharmacokinet 23: 22-24.
29. Schwartz CE, May MM, Carpenter NJ, et al, 2005 Allan- Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77: 41-53.
30. Maranduba CM, Friesema EC, Kok F, et al, 2006 Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. J Med Genet 43: 457-460.
31. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S, 2004 A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74: 168-175.
32. Heuer H, Visser TJ, 2009 Minireview: Pathophysiological importance of thyroid hormone transporters. Endocrinology 150: 1078-1083.
33. Trajkovic-Arsic M, Visser TJ, Darras VM, et al, 2010 Consequences of monocarboxylate transporter 8 deficiency for renal transport and metabolism of thyroid hormones in mice. Endocrinology 151: 802-809.
34. Trajkovic M, Visser TJ, Mittag J, et al, 2007 Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117: 627-635.
35. Wirth EK, Roth S, Blechschmidt C, et al, 2009 Neuronal 3', 3, 5- Triiodothyronine(T3) uptake and behavioral phenotype of mice deficient in MCT8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neuroscience 29: 9439-9449.
36. Papadimitriou A, Dumitrescu AM, Papavasiliou A, Fretzayas A, Nicolaidou P, Refetoff S, 2008 A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay Pediatrics 121: 199-202.
37. Biebermann H, Ambrugger P, Tarnow P, von Moers A, Schweizer U, Grueters A, 2005 Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. Eur J Endocrinol 153: 359-366.
38. Zung A, Visser TJ, Uitterlinden AG, Rivadeneira F, Friesema EC, 2011 A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment. Eur J Endocrinol 165: 823-830.
39. Di Cosmo C, Liao XH, Dumitrescu AM, Weiss RE, Refetoff S, 2009 A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport. Endocrinology 150: 4450-4458.
40. Pennock GD, Raya TE, Bahl JJ, Goldman S, Morkin E, 1992 Cardiac effects of 3,5- diiodothyroninepropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther 263: 163-169.
41. Morkin E, Pennock GD, Spooner PH, et al, 2002 Clinical and experimental studies on the use of 3,5- diiodothyropropionic acid, a thyroid hormone, in heart failure. Thyroid 12: 527-533.
42. Mebis L, van den Berghe G, 2009 The hypothalamuspituitary- thyroid axis in critical illness. Neth J Med 67: 332-340.
43. Utiger RD, 1980 Decreased extrathyroidal triiodothyronine production in non-thyroidal illness: benefit or harm? Am J Med 67: 807-810.
44. Hennermann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ, 2001 Plasma membrane trans port of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22: 451-476.
45. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR, 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89.
46. Fliers E, Alkemade A, Wiersinga WM, 2001 The hypothalamic- pituitary-thyroid-axis in critical illness. Best Pract Res Clin Endocrinol Metab 15: 453-464.
47. Mebis L, Paletta D, Debaveye Y, et al, 2009 Expression of thyroid hormone transporters during critical illness. Eur J Endocrinol 61: 243-250.
48. Peeters RP, Wooters PJ, Kaptein E, van Toor H, Visser TJ, van den Berghe G, 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88: 3202-3211.
49. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ, 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22: 1357-1369.
50. Ramadan T, Camargo SM, Summa V, et al, 2006 Basolateral aromatic aminoacid transporter TAT (Slc16a10) functions as an efflux pathway. J Cell Physiol 206: 771-779.
51. Ramadan T, Camargo SM, Herzog B, Bordin M, Pos KM, Verrey F, 2007 Recycling of aromatic aminoacids via TAT 1 allows efflux of neutral amino acids via LAT 2-4f2hc exchanger. Pflugers Arch 454: 507-516.
52. Sugiyama D, Kusuhara H, Taniguchi H, et al, 2003 Functional characterization of the rat brain-specific organic ion transporter (OAT P14) at the blood-brain barrier. J Biol Chem 278: 43489-43495.
53. Roberts LM, Woodford K, Zhou M, et al, 2008 Expression of the thyroid hormone transporters, monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149: 6251-6261.
54. Ceballos A, Belinchon MM, Sanchez-Mendoza E, et al, 2009 Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3'- triiodo-L-thyronine. Endocrinology 150: 2491-2496.